Cite
Prokopi A, Tripp CH, Tummers B, et al. Skin dendritic cells in melanoma are key for successful checkpoint blockade therapy. J Immunother Cancer. 2021;9(1)doi: 10.1136/jitc-2020-000832.
Prokopi, A., Tripp, C. H., Tummers, B., Hornsteiner, F., Spoeck, S., Crawford, J. C., Clements, D. R., Efremova, M., Hutter, K., Bellmann, L., Cappellano, G., Cadilha, B. L., Kobold, S., Boon, L., Ortner, D., Trajanoski, Z., Chen, S., de Gruijl, T. D., Idoyaga, J., Green, D. R., & Stoitzner, P. (2021). Skin dendritic cells in melanoma are key for successful checkpoint blockade therapy. Journal for immunotherapy of cancer, 9(1), . https://doi.org/10.1136/jitc-2020-000832
Prokopi, Anastasia, et al. "Skin dendritic cells in melanoma are key for successful checkpoint blockade therapy." Journal for immunotherapy of cancer vol. 9,1 (2021). doi: https://doi.org/10.1136/jitc-2020-000832
Prokopi A, Tripp CH, Tummers B, Hornsteiner F, Spoeck S, Crawford JC, Clements DR, Efremova M, Hutter K, Bellmann L, Cappellano G, Cadilha BL, Kobold S, Boon L, Ortner D, Trajanoski Z, Chen S, de Gruijl TD, Idoyaga J, Green DR, Stoitzner P. Skin dendritic cells in melanoma are key for successful checkpoint blockade therapy. J Immunother Cancer. 2021 Jan;9(1). doi: 10.1136/jitc-2020-000832. PMID: 33408092; PMCID: PMC7789456.
Copy
Download .nbib